Abstract: An oil-resistant agent containing a modified natural product which is a bio-based compound having at least one carboxyl group and in which a hydroxyl group of a carboxyl group is substituted with an R group, or a carboxyl group is substituted with an Ra group. R group: —X—R1 or —X-D-X?—R1. Ra group: wherein X is a direct bond, —O—, —NR11—, or —S—, and R1 is a hydrocarbon group having 1-40 carbon atoms, or a polysiloxane, D is an alkylene group having 1-10 carbon atoms, X? is —C(?O)—O—, —O—(?O)—, —C(?O)—NR12—, or —NR12—C(?O)— (where, R11 and R12 are each hydrogen or an alkyl group having 1-40 carbon atoms). Also disclosed is a textile product, an oil-resistant paper, a food packaging material or a food container each including the oil-resistant agent, as well as a method of treating paper with the oil-resistant agent.

Abstract: A Cd-free blue fluorescent quantum dot with a narrow fluorescence FWHM. The quantum dot does not contain cadmium and its fluorescence FWHM is 25 nm or less. The quantum dot is preferably a nanocrystal containing zinc and selenium or zinc and selenium and sulfur. Further, the quantum dot preferably has a core-shell structure in which the nanocrystal serves as a core and the surface of the core is coated with a shell.

Abstract: Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.

Abstract: Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.

Abstract: Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.

Abstract: Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.

Abstract: When a portable information ratio terminal device receives impact (external force) due to falling down or the like, electrical connection of an electronic part mounted on a substrate in the device body is held. The portable information terminal device includes the device body (1H) consisted of mutually combined first and second casings (3) and (4), a printed board (2) provided in the device body and mounting an electronic part (6) and an elastic body (6) supporting the printed board on the device body. The elastic body is provided between the printed board and the first casing and between the printed board and the second casing.